1005-1007
Editorial
Determining the role of radiotherapy in the adjuvant management of gastric cancer: an ocean apart
Benjamin W. Corn and Ravit Geva
1009-1021
Original Article
A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer
Aristotelis Bamias, M. Karina, P. Papakostas, I. Kostopoulos and M. Bobos, et al.
1023-1028
Original Article
Open AccessErlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer
Matthew K. Wong, Alvis I. Lo, Bing Lam, W. K. Lam and Mary S. Ip, et al.
1029-1037
Original Article
Beneficial effect of metronomic chemotherapy on tumor suppression and survival in a rat model of hepatocellular carcinoma with liver cirrhosis
Seong Tae Park, Jeong Won Jang, Gi Dae Kim, Joung Ah Park and Wonhee Hur, et al.
1039-1046
Original Article
LLL-3, a STAT3 inhibitor, represses BCR-ABL-positive cell proliferation, activates apoptosis and improves the effects of Imatinib mesylate
Andre Luiz Mencalha, B. Du Rocher, D. Salles, R. Binato and E. Abdelhay
1047-1056
Original Article
Differential roles of Trk and p75 neurotrophin receptors in tumorigenesis and chemoresistance ex vivo and in vivo
Muriel Bassili, Elena Birman, Nina F. Schor and H. Uri Saragovi
1057-1066
Original Article
Pharmacokinetics of carboplatin and etoposide in infant neuroblastoma patients
Gareth J. Veal, Michael Cole, Julie Errington, Andrew D. J. Pearson and Mary Gerrard, et al.
1067-1081
Original Article
The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines
Allison Pledgie-Tracy, Madhavi Billam, Amy Hacker, Michele D. Sobolewski and Patrick M. Woster, et al.
1083-1091
Original Article
In vitro comparison of O4-benzylfolate modulated, BCNU-induced toxicity in human bone marrow using CFU-GM and tumor cell lines
Holger Peter Behrsing, Michael J. Furniss, Kristine A. Robillard, Joseph E. Tomaszewski and Ralph E. Parchment
1093-1099
Original Article
Phase II study of S-1 as first-line treatment for elderly patients over 75 years of age with advanced gastric cancer: the Tokyo Cooperative Oncology Group study
Wasaburo Koizumi, Toshikazu Akiya, Atsushi Sato, Toshikazu Sakuyama and Eisaku Sasaki, et al.
1101-1107
Original Article
Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer
Takashi Sasaki, Hiroyuki Isayama, Yousuke Nakai, Yukiko Ito and Hirofumi Kogure, et al.
1109-1116
Original Article
Pharmacokinetics and enhanced bioavailability of candidate cancer preventative agent, SR13668 in dogs and monkeys
Izet M. Kapetanovic, Miguel Muzzio, Shu-Chieh Hu, James A. Crowell and Roger A. Rajewski, et al.
1117-1123
Original Article
Oxidative stress and enhanced paracellular permeability in the small intestine of methotrexate-treated rats
Tomoko Maeda, Yuko Miyazono, Kousei Ito, Kazuma Hamada and Shuichi Sekine, et al.
1125-1130
Original Article
Clinical potency of methotrexate, aminopterin, talotrexin and pemetrexed in childhood leukemias
Robin E. Norris and Peter C. Adamson
1131-1136
Original Article
PSC833, cyclosporine analogue, downregulates MDR1 expression by activating JNK/c-Jun/AP-1 and suppressing NF-κB
H. Bark and Cheol-Hee Choi
1137-1143
Original Article
Zoledronic acid in the treatment of bone metastases by hepatocellular carcinoma: a case series
Liliana Montella, Raffaele Addeo, Giovannella Palmieri, Michele Caraglia and Gregorio Cennamo, et al.
1145-1152
Original Article
Pharmacokinetics and distribution of SN 28049, a novel DNA binding anticancer agent, in mice
Pradeep B. Lukka, James W. Paxton, Philip Kestell and Bruce C. Baguley
1153-1163
Original Article
Heterogeneity of epithelial and stromal cells of head and neck squamous cell carcinomas in ex vivo chemoresponse
Iris-Susanne Horn, Gunnar Wichmann, Christian Mozet, Andreas Dietz and Ralph Dollner, et al.
1165-1172
Original Article
Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data
Anne von Heideman, Åke Berglund, Rolf Larsson and Peter Nygren
1173-1189
Original Article
Medulloblastoma in childhood: revisiting intrathecal therapy in infants and children
Sharon Conroy, Martin Garnett, Michael Vloeberghs, Richard Grundy and Ian Craven, et al.
1191-1195
Short Communication
Novel d-erythro N-octanoyl sphingosine analogs as chemo- and endocrine-resistant breast cancer therapeutics
James W. Antoon, Jiawang Liu, Adharsh P. Ponnapakkam, Matthew M. Gestaut and Maryam Foroozesh, et al.
1197-1202
Short Communication
Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, in combination with cisplatin in patients with advanced non-small-cell lung cancer
Orazio Caffo, Stefania Fallani, Elena Marangon, Stefania Nobili and Maria Iris Cassetta, et al.
1203-1207
Short Communication
Population pharmacokinetic study of a test dose oral busulfan in Japanese adult patients undergoing hematopoietic stem cell transplantation
Yasushi Takamatsu, Noriaki Sasaki, Kentaro Ogata, Eiji Yukawa and Shiro Jimi, et al.